Market Insights Health OTC Pharmaceuticals

Analgesics - Egypt

Egypt

In Egypt, the revenue generated in the Analgesics market in 2024 amounts to US$244.30.
It is projected that the market will experience an annual growth rate of 13.63% (CAGR 2024-2029).
When comparing the revenue on a global scale, the in the United States leads the way, generating US$7,243.00 in 2024.
Taking into account the total population figures, it can be observed that in Egypt, each person generates per person revenues of US$2.13 in 2024.
Egypt's analgesics market is witnessing a surge in demand due to the increasing prevalence of chronic pain and the growing awareness of self-medication.

Key regions: Brazil, Europe, Germany, Canada, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in Egypt is experiencing significant growth and development.

Customer preferences: Egyptian consumers have shown a growing preference for analgesics as a means to manage pain and discomfort. This can be attributed to several factors, including an increasing awareness of the importance of self-care and the availability of a wide range of analgesic products in the market. Additionally, the convenience and affordability of over-the-counter analgesics have made them a popular choice among consumers.

Trends in the market: One of the key trends in the Analgesics market in Egypt is the shift towards natural and herbal remedies. Consumers are increasingly seeking products that are perceived as more natural and have fewer side effects. As a result, there has been a rise in the demand for analgesics that are derived from natural ingredients, such as herbal extracts and essential oils. This trend is driven by a growing interest in holistic health and wellness, as well as a desire to reduce reliance on synthetic medications.Another trend in the market is the increasing availability of analgesics in different formats. While traditional tablets and capsules continue to dominate the market, there has been a rise in the popularity of alternative formats, such as gels, creams, and patches. These formats offer targeted relief and are seen as more convenient and user-friendly by consumers.

Local special circumstances: Egypt has a large population, with a significant portion of the population experiencing chronic pain and other health issues that require analgesic treatment. This has created a high demand for analgesics in the market. Additionally, the country's healthcare system is still developing, and access to healthcare services can be limited in certain areas. As a result, many consumers rely on over-the-counter analgesics as a primary means of pain management.

Underlying macroeconomic factors: Egypt has experienced steady economic growth in recent years, which has contributed to an increase in disposable income among consumers. This has allowed more consumers to afford analgesic products and has contributed to the overall growth of the market. Additionally, the government has implemented healthcare reforms aimed at improving access to healthcare services, which has further fueled the demand for analgesics.In conclusion, the Analgesics market in Egypt is witnessing significant growth and development, driven by customer preferences for convenience, affordability, and natural remedies. The market is also influenced by local special circumstances, such as a large population with limited access to healthcare services. The underlying macroeconomic factors, including economic growth and healthcare reforms, have further contributed to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.